Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. (Record no. 30321174)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02334 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518071226.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202001s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-547X |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S0140-6736(19)32556-5 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Attal, Michel |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200106 |
| 245 00 - TITLE STATEMENT | |
| Title | Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Lancet (London, England) |
| Date of publication, distribution, etc. | 12 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2096-2107 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Video-Audio Media |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Asia |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dexamethasone |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Europe |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Multiple Myeloma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Recurrence, Local |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | North America |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Progression-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Thalidomide |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Richardson, Paul G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rajkumar, S Vincent |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | San-Miguel, Jesus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Beksac, Meral |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Spicka, Ivan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leleu, Xavier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schjesvold, Fredrik |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moreau, Philippe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dimopoulos, Meletios A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Huang, Jeffrey Shang-Yi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Minarik, Jiri |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cavo, Michele |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Prince, H Miles |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Macé, Sandrine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Corzo, Kathryn P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Campana, Frank |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Le-Guennec, Solenn |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dubin, Franck |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Anderson, Kenneth C |
| 773 0# - HOST ITEM ENTRY | |
| Title | Lancet (London, England) |
| Related parts | vol. 394 |
| -- | no. 10214 |
| -- | p. 2096-2107 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S0140-6736(19)32556-5">https://doi.org/10.1016/S0140-6736(19)32556-5</a> |
| Public note | Available from publisher's website |
No items available.